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Type 2 diabetes (T2D) is associated with accelerated atherosclerosis, which accounts for approximately 75% of all diabetes-
related deaths. Here we investigate the link between diabetes and macrophage cholesteryl ester accumulation. When diabetic
(db/db) mice are given cholesteryl ester intraperitoneally (IP), peritoneal macrophages (PerMWs) recovered from these animals
showed a 58% increase in intracellular cholesteryl ester accumulation over PerMWs from heterozygote control (db/+) mice.
Notably, PerMW fluid-phase endocytosis and large particle phagocytosis was equivalent in db/+and db/db mice. However, IP
administration of CD36 and SR-A blocking antibodies led to 37% and 25% reductions in cholesteryl ester accumulation in
PerMW. Finally, in order to determine if these scavenger receptors (SRs) were part of the mechanism responsible for the
increased accumulation of cholesteryl esters observed in the diabetic mouse macrophages, receptor expression was quantified
by flow cytometry. Importantly, db/db PerMWs showed a 43% increase in CD36 expression and an 80% increase in SR-A
expression. Taken together, these data indicate that direct cholesteryl ester accumulation in mouse macrophages is mediated
by CD36 and SR-A, and the magnitude of accumulation is increased in db/db macrophages due to increased scavenger
receptor expression.
Citation: Guest CB, Hartman ME, O’Connor JC, Chakour KS, Sovari AA, et al (2007) Phagocytosis of Cholesteryl Ester Is Amplified in Diabetic Mouse
Macrophages and Is Largely Mediated by CD36 and SR-A. PLoS ONE 2(6): e511. doi:10.1371/journal.pone.0000511
INTRODUCTION
T2D is an independent risk factor for developing atherosclerosis
[1]. Accelerated atherosclerosis accounts for the majority of all
diabetes-related deaths [2]. In addition, patients with T2D are 2 to
4 times more likely to develop atherosclerosis [3]. The incidence of
individuals with diabetes who suffer a myocardial infarction is
20.2% compared to 3.5% for those without diabetes, following
a second heart attack these numbers substantially increase to
45.0% and 18.8%, respectively [4]. Dyslipidemia, hypertension,
oxidation state, endothelial cell function, hyperglycemia, insulin
resistance, and advanced glycation end-products (AGEs) have
been shown to play a role in diabetes-accelerated atherosclerosis
[5][6][7]. However, it has not been determined if direct cholesteryl
ester uptake by macrophages and subsequent foam cell formation
may be altered in the diabetic state contributing to diabetes-
accelerated atherosclerosis.
The storage of cholesteryl esters in macrophages and the
subsequent formation of foam cells are critical to the development
of the atherosclerotic plaque [8]. Both cholesteryl ester-rich oily
droplets and cholesterol-rich vesicles are found within the early
fatty streak and lipid core, with cholesteryl esters more prominent
in the fatty streak and advanced plaques [9][10]. Macrophages
have been shown to directly take up both free cholesterol [11] and
cholesteryl esters [12] through an as yet incompletely defined
mechanism, resulting in the generation of foam cells. Initially in
macrophage-derived foam cell development, monocytes migrate
into the arterial intima stimulated by any or all of the following:
tumor necrosis factor a, interleukin-1, 6, 8, 10, 12, oxidized LDL,
monocyte chemoattractant protein 1-5, macrophage colony-
stimulating factor, granulocyte/macrophage colony-stimulating
factor, migratory inflammatory protein-1, transforming growth
factor-b, RANTES, and endothelin-1 [13]. These monocytes then
differentiate into macrophages and take up modified LDLs [13],
which leads to the formation of foam cells through the
accumulation of cholesteryl esters. LDLs are transported into
lysosomes, where cholesteryl esters are hydrolyzed by acid
hydrolase into free cholesterol. Cholesteryl ester repeatedly
undergoes hydrolysis and re-esterification in the ‘‘cholesterol ester
cycle’’ by neutral cholesterol ester hydrolase and acyl coenzyme
A:cholesterol acyltransferase (ACAT), respectively [14]. Choles-
terol in this process turns over with a half time of approximately
24 h [15]. The free cholesterol is exported from the cell or trapped
in the cytosol as cholesteryl esters. Eventually, the accumulation of
free cholesterol is toxic to the foam cell resulting in apoptosis [16]
or necrosis [13], which contributes to the formation of the lipid
core of the atherosclerotic plaque [17]. Tangirala et al.
demonstrated that this same lysosomal accumulation of cholesterol
occurs in macrophages loaded with cholesteryl esters through
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can proliferate within the atherosclerotic lesion [19] and activated
macrophages can produce growth regulatory molecules, cytokines,
and chemotactic factors [20], leading to atheroma progression.
SRs are integral to the development of foam cells in that they
mediate the uptake of modified LDLs by macrophages [21][22].
SRs were initially identified by Goldstein et al. with the discovery
that macrophages take up acetylated LDL through a specific
surface binding site that does not recognize native LDL [23].
Currently the scavenger receptor family consists of 6 structurally
distinct classes of receptors (classes A through F) that bind a range
of polyanionic ligands including modified LDLs [22]. Scavenger
receptor A (SR-A) or CD204, and CD36, a class B member, have
been shown to play a major role in the uptake of modified LDLs
[24][25]. Stangl et al. extended the role of scavenger receptors
to include SR-BI mediated cholesteryl ester formation in the
presence of free cholesterol [26], indicating that the scavenger
receptor system plays a role in direct cholesterol uptake. Liang et
al. further characterized the relationship between scavenger
receptors and uptake of modified LDLs in a model of diabetes.
This group demonstrated that due to defective insulin signaling,
but independent of glucose and free fatty acids, macrophages from
ob/ob mice express higher levels of SR-A and CD36 resulting in
elevated cellular association with acetylated and oxidized LDL and
increased cholesteryl ester formation [7]. In addition, reversal of
insulin resistance in ob/ob mice with rosiglitazone, a peroxisome
proliferator-activated receptor (PPAR) c agonist, leads to de-
creased CD36 expression on PerMWs [7]. Importantly, patients
with T2D have increased CD36 expression on monocytes [27].
These studies demonstrate a plausible role for altered expression of
scavenger receptors, specifically CD36 and SR-A in diabetes-
associated atherosclerosis.
In summary, patients with T2D patients have an increased risk
for developing atherosclerosis and the direct uptake of cholesteryl
esters by macrophages following initiation of plaque development
[9][10] represents an important mechanism for foam cell
formation [12]. However, the impact of diabetes on direct
cholesteryl ester uptake by macrophages, which may play a role
in plaque progression and perpetuation, has not been investigated.
Therefore, we examined the hypothesis that macrophages from
type-2 diabetic (db/db) mice have increased direct cholesteryl ester
uptake and that this is mediated by CD36 and SR-A.
MATERIALS AND METHODS
Materials
All cell culture reagents and chemicals were purchased from
Sigma (St. Louis, MO) except as noted below. Lipoprotein (LDL)
(cat# L-5402) and Lippoprotein (HDL) (cat#L-1567) were
purchased from Sigma (St. Louis, MO). FBS (0.05 ng/ml, 0.48
EU/ml endotoxin) was purchased from Atlanta Biologicals
(Norcross, GA). Bodipy-cholesteryl ester (cat# C-3927), Dil-
acetylated LDL (cat# L-3484) and propidium iodide were
purchased from Molecular Probes (Eugene, OR). TriColor-anti-
mouse CD11b (cat# RM2806) and TriColor-rat IgG2b (cat#
R2b06) were purchased from Caltag (Hamburg, Germany).
Phycoerytherin-anti-mouse CD86 (cat# MCA1587PE), Phycoer-
ytherin-rat IgG2a (cat# MCA1212PE), anti-mouse CD204 (SR-
A) (cat# MCA1322), FITC-anti-mouse CD204 (SR-A) (cat#
MCA1322F), and rat IgG2b (cat# MCA1125R) were purchased
from Serotec (Raleigh, NC). 0.21 mm and 2.6 mm microspheres
were purchased from Bangs Laboratories, Inc (Fishers, IN). Anti-
mouse CD36 (cat# 552554), FITC-anti-mouse IgA (cat#
559354), FITC-rat-IgG2b (cat# 556923), and mouse IgA (cat#
553476) were purchased from Pharmingen, BD Biosciences (San
Diego, CA). Anti-SR-BI (cat# NB 400-113 and NB 400-104E2)
and FITC-anti-rabbit IgG (cat# NB 730-F) were purchased from
Novus Biologicals (Littleton, CO). One Touch Ultra glucometer
and glucose strips were purchased from Lifescan, Johnson&John-
son (Milpitas, CA). Sensitive Rat Insulin radioimmunoassay kit
was purchased from Linco Research, Inc. (St. Charles, MO).
Animals
All animal care and use was conducted in accordance with the
Guide for the Care and Use of Laboratory Animals (NRC). 8- to
12-week-old B6.Cg-M+/+Lepr
db (db/+) and B6.Cg-+Lepr
db/+Lepr
db
(db/db) were bred in house from mice purchased from The Jackson
Laboratories (Bar Harbor, Maine). Mice were housed in standard
shoebox cages and allowed pelleted food (NIH 5K52; LabDiet,
Purina Mills Inc., Brentwood, MO) and water ad libitum in
a temperature (72uC) and humidity (45–55%) controlled environ-
ment with a 12/12-h dark-light cycle (7:00 a.m.–7:00 p.m.).
Peritoneal Macrophage Isolation
Mice were sacrificed by CO2 asphyxiation and peritoneal fluid was
collected by lavaging the peritoneums twice with 5 ml ice cold low
glucose growth media (glucose-free RPMI 1640 media supple-
mented with 10% FBS, 1 g/L glucose, 2 g/L sodium bicarbonate,
110 mg/L sodium pyruvate, 62.1 mg/L penicillin and 100 mg/L
streptomycin, 10 mM HEPES pH 7.4), followed immediately by
analysis or use in ex vivo experiments. For ex vivo experiments, cells
were plated according to the following procedure. Peritoneal fluid
was centrifuged and the resulting pellet resuspended in 5 ml of red
blood cell lysis buffer (142 mM NaCl, 118 mM NaEDTA, 1 mM
KHCO3 pH 7.4) at room temperature for 4 minutes. An equal
volume of cold low glucose growth media was added followed by
cell pelleting and resuspension in 37uC low glucose growth media.
Cells were counted with the use of a hemocytometer and plated in
culture dishes at 5610
5 cells/ml in low glucose growth media.
After 30 min, plates were washed twice to remove non-adherent
cells, resulting in approximately 80% pure macrophages, con-
firmed by CD11b staining and morphology [28]. Immediately
following plating selection, peritoneal macrophages were used for
Dil-AcLDL or bodipy-cholesteryl ester uptake experiments.
Blood Glucose and Serum Insulin Measurement
Blood was collected from the lateral saphenous vein of 8-week-old
db/+and db/db mice. Blood glucose levels were measured during
collection using a One Touch UltraH glucometer per the
manufacturer’s instructions. For random and fasting blood glucose
measurements, blood was collected at 9:00 a.m. from mice fed ad
libitum or fasted overnight, respectively. Serum insulin levels were
measured by RIA according to the manufacturer’s instructions.
For random serum and fasting, blood was collected as above and
serum was collected by centrifuging blood for 10 min at 16,0006g
and stored at 220uC.
CD11b/86 and CD36/SR-A Staining
After indicated treatments, PerMWs were harvested as described
above. Flow cytometry was performed as previously described
[29]. In brief, cells were washed once in wash buffer (Dulbecco’s
phosphate-buffered saline (DPBS) containing 0.5% BSA without
calcium and magnesium). TriColor, Phycoerytherin and/or
FITC-conjugated antibodies at 10 mg/ml/test were added to
1610
6 cells in 100 ml of wash buffer then incubated on ice for
15 min followed by washing with wash buffer. Fluorescence was
detected on an Epics XL flow cytometer (Beckman Coulter,
Cholesteryl Ester in MWs
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double positive cells and to exclude nonviable cells as determined
by propidium iodide staining.
Cholesterol and Particle Uptake
Cholesteryl ester labeled 1:1 with an ester bodipy tag, was
dissolved in MeOH at 0.5 mg/ml by sonication for 60 min
followed by sonication for 15 min prior to administration.
Microscopic imaging studies of 5 mg/ml cholesteryl ester in sterile
wash buffer demonstrated a non-homogeneous population local-
ized to the coverslip, indicating that cholesteryl ester forms
aggregates in a hydrophilic solution (Laboratory of Fluorescence
Dynamics, University of Illinois, Urbana IL). Size was determined
to range from approximately 1 mm to 3.5 mm (data not shown).
For ex vivo particle uptake, cells were treated as indicated and
allowed to incubate for 4 h at 37uC with 5 mg/ml bodipy-
cholesteryl ester and stained with propidium iodide as above. To
control for non-specific uptake, cells were treated as above and
incubated for 4 h on ice with 5 mg/ml bodipy-cholesteryl ester.
For in vivo uptake, mice were given an IP injection of 1 ml sterile
filtered wash buffer containing either 5 mg/ml bodipy-cholesteryl
ester, 5 mg/ml Dil-AcLDL, 5610
7 2.6 mm beads, 5610
9 0.21 mm
beads, or 0.25 mg/ml FITC-dextran as indicated. After 4 h or as
indicated, PerMWs were harvested as described above without re-
exposure to bodipy-cholesteryl ester ex vivo. Fluorescence was
detected on an Epics XL flow cytometer (Beckman Coulter,
Fullerton, CA). Gates were set to exclude nonviable cells as
determined by propidium iodide staining. Cholesteryl ester uptake
was quantified as previously described [30]; in brief, samples were
excited at 490 nm and fluorescence was measured at 530 nm (554
and 571 for Dil-AcLDL), uptake was quantified by subtracting
median fluorescence of control cells from median fluorescence of
cells treated with bodipy-cholesteryl ester or Dil-AcLDL.
CD36/SR-A, LDL/HDL Blocking Experiments
In vivo cholesterol uptake was performed as above. Mice were given
an IP injection of 1 ml sterile filtered wash buffer containing 5 mg/
ml bodipy-cholesteryl ester with 5 mg/ml of either anti-CD36,
anti-SR-A, isotype control, 20 mg/ml LDL or 20 mg/ml HDL.
After the times indicated, PerMWs were harvested as described
above. Ex vivo AcLDL uptake was performed as above for ex vivo
cholesteryl ester uptake. Cells were incubated with 10 mg/ml of
either anti-CD36, anti-SR-A, or isotype control for 15 m on ice.
5 mg/ml of Dil-AcLDL was added and cells incubated for 4 h.
Fluorescence was detected as above. Gates were set to exclude
nonviable cells as determined by propidium iodide staining.
Median values of each population were used to indicate the level
of cholesteryl ester uptake or AcLDL.
Statistical Analysis
Where indicated, experimental data were analyzed either by the
Student’s t-test for comparison of means, or by ANOVA using
Excel (Microsoft, Redmond WA). Statistical significance was
denoted at p,0.05. Standard-error-of-the-mean bars are not
shown when the error range is smaller than the symbol size.
RESULTS
PerMWs from db/db mice have increased AcLDL and
cholesteryl ester uptake
To determine if AcLDL or cholesteryl ester uptake was affected by
diabetes, we examined resident PerMWs from db/db and db/+mice.
Db/db mice are characterized by hyperphagia, obesity, hyper-
insulinemia and hyperglycemia (Table 1). One potential mecha-
nism for the increased accumulation of lipids by diabetic MWsi s
increased uptake of modified LDL. When Dil-AcLDL was
administered IP, AcLDL uptake by PerMWs in vivo was increased
by 256% in db/db mice compared to db/+mice (p,0.001) (Fig. 1A).
Next, direct uptake of cholesteryl ester was measured. Fig. 1B
shows that when bodipy-cholesteryl ester was administered IP for
4 h, cholesteryl ester uptake by PerMWs in vivo was increased by
58% in db/db mice compared to db/+mice (p,0.01). Importantly,
intracellular localization of bodipy-cholesteryl ester was confirmed
by fluorescent microscopy (Fig. 1C). To ascertain if PerMWs from
db/db mice had increased cholesteryl ester uptake that required the
involvement of a peritoneal factor, PerMWs isolated and cultured
from db/db and db/+mice were examined ex vivo. Fig. 1D shows
that, when cultured PerMWs from db/db and db/+mice were
incubated with bodipy-cholesteryl ester for 4 h, cholesteryl ester
uptake was increased by 59% (p,0.01) in db/db mouse PerMWs.
These results indicate that PerMWs from db/db mice have
increased ability to take up AcLDL in vivo and cholesteryl esters
both in vivo and ex vivo.
Large particle phagocytosis and fluid-phase
endocytosis are not increased in PerMWs from
db/db mice
The mechanism by which cholesteryl esters are taken up by
macrophages is not well defined. Cholesteryl esters can enter the
cell via receptor-mediated endocytosis or alternatively, cholesteryl
esters in solution may form microcrystals [31] that can be ingested
by phagocytosis or fluid-phase endocytosis. To determine if
phagocytosis was increased in db/db PerMWs, we examined
0.21 mm microsphere and 2.6 mm microsphere uptake [32].
Fig. 2A shows that PerMWs from db/db mice did not have
increased microsphere uptake when compared to PerMWs from
db/+mice (0.21 mm, p=0.609; 2.6 mm, p=0.260). Likewise, we
examined fluid-phase endocytosis in db/db PerMWs utilizing
dextran [32]. Fig. 2B demonstrates that PerMWs from db/db mice
did not have increased uptake of dextran over PerMWs from
db/+mice (p=0.450). These results indicate that large particle
phagocytosis and fluid-phase endocytosis are not increased in
db/db mouse PerMWs.
CD36 and SR-A mediate amplified AcLDL and
cholesteryl ester uptake in db/db PerMWs
Macrophages take up modified LDLs through scavenger receptors
leading to the formation of foam cells [8]. The class B scavenger
receptor CD36 and the class A scavenger receptor SR-A are
Table 1. Db/db mice have elevated blood glucose and serum
insulin levels.
......................................................................
db/+ db/db
Body Wt (g) 27.2860.79 38.8860.84*
FBG (mg/dl) 95.6610.57 408.8652.77*
RBG (mg/dl) 154.6614.03 434.0650.88*
FSI (ng/ml) 1.3660.23 2.3660.045*
RSI (ng/ml) 2.0460.48 (0.356 nM) 5.3460.11* (0.932 nM)
Fasting blood glucose (FBG), random blood glucose (RBG), fasting serum insulin
(FSI), and random serum insulin (RSI). Results represent the average of n=5
mice6SEM. *: p,0.05.
doi:10.1371/journal.pone.0000511.t001
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and are increased in the presence of insulin resistance [7]. To
determine the relative importance of CD36 and SR-A in the
uptake of AcLDL in db/+and db/db PerMWs ex vivo antibody-
dependent blocking experiments were performed. Fig. 3A shows
that when anti-CD36 was administered to PerMWs from db/
+mice, AcLDL uptake was not significantly different than isotype
control (p=0.06). As expected, administration of anti-SR-A
blocked more than 50% of AcLDL uptake when compared to
isotype control (p,0.0001). Next, we examined the effect of these
antibodies on AcLDL uptake in db/db PerMWs. Fig. 3B shows that
anti-CD36 decreased AcLDL uptake by 15% (p,0.001). Similar-
ly, as seen in db/+PerMWs, anti-SR-A significantly reduced the
uptake of AcLDL by 48% (p,0.0002). Taken together these
results indicate that SR-A plays an important role in the uptake of
AcLDL in both db/+and db/db PerMWs, however, CD36 appears
only to significantly impact AcLDL uptake in db/db PerMWs.
Next, the role of CD36 and SR-A in cholesteryl ester uptake was
examined using in vivo antibody-dependent blocking of CD36 and
SR-A. Fig. 3C shows that, when anti-CD36 and anti-SR-A were
administered IP to db/+mice, in vivo PerMW cholesteryl ester
uptake was reduced by 37% (p,0.01) and 25% (p,0.05) when
compared to isotype controls, respectively, indicating that CD36
and SR-A mediate the uptake of cholesteryl ester. Similarly, when
anti-CD36 and anti-SR-A were administered IP to db/db mice, in
vivo PerMW cholesteryl ester uptake was reduced by 31% (p,0.01)
and 28% (p,0.05), respectively (Fig. 3D). Finally, to determine if
expression of CD36 and/or SR-A were increased in PerMWs from
db/db mice, flow cytometry was performed. Fig. 3E demonstrates
that db/db mouse PerMWs had a 43% increase in CD36 expression
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Figure 1. PerMWs from db/db mice have increased AcLDL and
cholesteryl ester uptake. A, db/+and db/db mice were administered
5 mg/mL of Dil-AcLDL by IP injection. After 4 h, PerMWs were collected
and Dil-AcLDL uptake measured by flow cytometry. B, db/+and db/db
mice were administered 5 mg/mL of bodipy-cholesteryl ester by IP
injection. After 4 h, PerMWs were collected and cholesteryl ester uptake
measured by flow cytometry. C, bodipy-cholesteryl ester (C.E) or carrier
(Con) were administered as in A for 4 h. PerMWs cholesteryl ester
uptake was examined using fluorescent microscopy. Results are
representative of three independent experiments. D, PerMWs were
collected from db/+and db/db mice and cultured for 30 min ex vivo.
Cells were then incubated with 5 mg/mL bodipy-cholesteryl ester (C.E.)
and cholesteryl ester uptake measured by flow cytometry at 4 h. Results
for A, B and D represent the average of three independent
experiments6SEM. *: p,0.05.
doi:10.1371/journal.pone.0000511.g001
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Figure 2. Phagocytosis and fluid-phase endocytosis are not increased
in PerMWsf r o mdb/db mice. A, Db/+and db/db mice were IP
administered 0.21 or 2.6 mm latex microspheres (beads) at 5610
9 or
5610
7 beads/ml, respectively. Following a 4 h in vivo incubation period,
PerMWs were collected and microsphere uptake was measured by flow
cytometry. B, Db/+and db/db mice were IP administered 0.25 mg/ml
FITC-dextran. Following a 4 h in vivo incubation period, PerMWs were
collected and dextran uptake was measured by flow cytometry. Results
for A and B represent the average of three independent experi-
ments6SEM.
doi:10.1371/journal.pone.0000511.g002
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pared to PerMWs from db/+mice (p,0.01). In order to determine
if physiologically relevant concentrations of LDL or HDL
mediated the uptake of cholesteryl esters, LDL or HDL were
administered as indicated above. Co-administration of LDL or
HDL failed to reduce the accumulation of cholesteryl ester (data
not shown). Taken together these results indicate that increased
CD36 and SR-A expression on db/db mouse PerMWs is re-
sponsible for enhanced AcLDL and direct cholesteryl ester uptake
observed in db/db mice.
DISCUSSION
Foam cell formation is central to the development and progression
of the atherosclerotic plaque [13,16,17,19,20]. Key components to
foam cell formation are macrophage ingestion and accumulation
of cholesteryl esters via SR-mediated uptake of modified LDLs [8]
and transport of cholesteryl esters across the membrane in
conjunction with HDL and reverse cholesterol transport [33].
We found that PerMWs from db/db mice have increased AcLDL
uptake compared to db/+controls (Fig. 1A). Given the central role
of SRs to this process, we conducted antibody blocking
experiments to determine the relative importance of CD36 and
SR-A in db/+and db/db PerMWs. Antibody blocking experiments
showed that anti-CD36 had little affect on AcLDL uptake in db/
+PerMWs while in db/db PerMWs anti-CD36 attenuated AcLDL
uptake 15%. This finding demonstrates an interesting phenotypic
difference between db/+and db/db PerMWs and may explain, in
part, the significant increase of AcLDL uptake seen in db/db
PerMWs. Next, the role of SR-A in AcLDL was examined. The
administration of anti-SR-A antibodies decreased AcLDL uptake
by 50% in db/+PerMWs and 48% in db/db PerMWs indicating that
the uptake of AcLDL is primarily mediated by SR-A rather than
CD36 (Fig. 3A–B). These findings support work by Liang et al.
which demonstrated that insulin resistance leads to increased
cellular uptake with AcLDL [7], although, in a different mouse
model of diabetes. Uptake of modified LDL by SRs and
accumulation of CE is well characterized but the importance of
SRs for direct CE uptake has yet to be investigated thoroughly
investigated [26]. In addition to cholesterol deposition through
lipoprotein metabolism, direct cholesterol and cholesteryl ester
uptake has been demonstrated in macrophages [11,12]. Currently
it is uncertain whether diabetic macrophages have increased direct
uptake of cholesteryl esters and how this may contribute to the
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Figure 3. CD36 and SR-A mediate increased AcLDL and cholesteryl
ester uptake in diabetic PerMWs. A, PerMWs were collected from db/
+mice and cultured for 30 min ex vivo. Cells were then incubated on ice
for 15 m with CD36, SR-A blocking antibodies (Ab) or isotype control
antibodies (Iso) as indicated. Cells were then incubated with 5 mg/ml
Dil-AcLDL and uptake measured by flow cytometry at 4 h. B, PerMWs
were collected from db/db mice and cultured for 30 min ex vivo. Cells
were then incubated on ice for 15 m with CD36, SR-A blocking
antibodies (Ab) or isotype control antibodies (Iso) as indicated. Cells
were then incubated with 5 mg/ml Dil-AcLDL and uptake measured by
flow cytometry at 4 h. C, Db/+mice were IP administered 5 mg/ml
bodipy-cholesteryl ester (C.E.) with CD36, SR-A blocking antibodies (Ab)
or isotype control antibodies (Iso) as indicated. After 4 h, PerMWs were
collected and cholesteryl ester uptake measured by flow cytometry. D,
Db/db mice were IP adminsitered 5 mg/ml bodipy-cholesteryl ester (C.E.)
with CD36, SR-A blocking antibodies (Ab) or isotype control antibodies
(Iso) as indicated. After 4 h, PerMWs were collected and cholesteryl ester
uptake measured by flow cytometry. E, PerMWs were collected from db/
+and db/db mice. CD36 and SR-A surface expression was measured by
flow cytometry. Results for A-E represent the average of three
independent experiments6SEM. *: p,0.05
doi:10.1371/journal.pone.0000511.g003
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from db/db mice have increased uptake of cholesteryl esters at
4 hours post IP administration. McGookey et al.[15] measured the
half-life of cholesteryl ester hydrolysis into cholesterol and fatty
acid subunits to be approximately 24 hours. Importantly, the
fluorescent bodipy label is conjugated to the fatty acyl moiety of
the cholesteryl ester indicating that an increase in intracellular
fluorescent bodipy label at 4 hours directly relates to an increase in
intracellular cholesteryl ester and not label alone. We have also
confirmed that the median fluorescence of the bodipy-cholesteryl
ester is linearly related to the mass of cholesteryl ester (data not
shown). To confirm that cholesteryl esters were taken into the cell
and not adhered to the cell surface, fluorescent microscopy was
performed. Fig. 1C demonstrates that cholesteryl esters were
located intracellularly. It is possible that the cholesteryl ester
injected IP formed liposomes with apoproteins present in the
peritoneal fluid or interacted with other peritoneal factors that led
to macrophage cholesteryl ester uptake. Fig. 1D, however,
demonstrates that PerMWs from db/+and db/db mice cultured ex
vivo had a similar cholesteryl ester uptake profile as PerMWs in vivo.
Thus, PerMWs directly take up cholesteryl esters independently
from any intraperitoneal factors and in diabetes this uptake is
increased. These findings are important because cholesteryl esters
are found in fatty streaks and in the lipid core of atheromas [9]
[10] thus plaque based macrophages in diabetes may utilize this
cholesteryl ester reservoir more readily to form foam cells than
non-diabetic macrophages.
The next question to address was how does the diabetic state
lead to increased cholesteryl ester uptake by PerMWs. Macro-
phages can ingest extracellular particles by receptor-mediated
endocytosis, fluid-phase endocytosis and/or phagocytosis. In order
to better define how diabetic macrophages ingest cholesteryl esters,
large particle phagocytosis and fluid-phase endocytosis was
examined via latex bead (Fig. 2A) and dextran (Fig. 2B) uptake,
respectively. As shown in Fig. 2, neither of these mechanisms of
ingestion differed between db/+and db/db mice. This indicated
that increased cholesteryl ester uptake was likely mediated by
receptor-mediated endocytosis. Mahlberg et al. demonstrated
uptake of cholesteryl ester lipid droplets by a phagocytic process
in J774 macrophages [12] and Stangl et al. demonstrated that
overexpression of SR-BI led to an increase in nonlipoprotein
cholesterol uptake by CHO cells [26]. Therefore, it seemed likely
that scavenger receptors may be involved in the uptake of
cholesteryl esters, especially SR-BI. However, SR-BI expression
was not detectable in peritoneal macrophages from either db/+or
db/db mice. SR-BI was detected on macrophage like RAW 264.7
cells (data not shown). Liang et al. recently demonstrated that
insulin resistance leads to increased expression of CD36 and SR-A
and cellular uptake of acetylated and oxidized LDL [7]. Our data
in Fig. 1A&Fig. 3E supports these findings in a different animal
model of diabetes. Additionally, we examined the relative
contribution of CD36 and SR-A to the uptake of AcLDL in
PerMWs from db/+and db/db mice. Fig. 3A demonstrates that
CD36 does not significantly contribute to the uptake of AcLDL in
db/+PerMWs. However, Fig. 3B shows that the administration of
anti-CD36 specific blocking antibodies significantly decreased the
uptake of AcLDL in db/db PerMWs. Since the same concentration
of anti-CD36 antibody was able to decrease the uptake of AcLDL
in the db/db PerMWs, it demonstrated that this antibody was
effective as a blocking antibody. This finding may be an important
phenotypic difference between the db/+and the db/db PerMWs, not
only with respect to modified LDL uptake, but it may impact the
innate immune response to ligands that interact with Toll-like-
receptor 2 (TLR-2), since CD36 has been identified as
costimulatory molecule for this TLR-2 [34]. Fig. 3C–D extends
these finding to show that CD36 and SR-A were linked to direct
cholesteryl ester uptake in PerMWs. Furthermore, since both of
these SRs are involved in direct cholesteryl ester uptake, increased
expression of CD36 and SR-A observed on db/db mouse PerMWs
(Fig. 3E) appears responsible for their enhanced cholesteryl ester
uptake by increasing the magnitude of uptake.
Lastly, the mechanism by which scavenger receptors mediate
direct cholesteryl ester uptake has not been delineated. One
possibility is that the cholesteryl esters interact with LDL or HDL
in some fashion that then results in uptake through these already
established mechanisms. However, neither co-administration of
LDL nor HDL was able to reduce IP cholesteryl ester uptake by
peritoneal macrophages (data not shown). This is not surprising
given work done by Goldstein et al. demonstrating that un-
modified LDL does not interact strongly with the scavenger
receptor system [23] and that the HDL receptor, SR-BI, was not
detected on PerMWs. Therefore, it appears that the scavenger
receptors CD36 and SR-A mediate direct uptake of cholesteryl
esters by macrophages through a mechanism distinct from LDL
and HDL uptake. Although at this time more work is required to
define the exact mechanism of direct cholesteryl ester uptake, our
data here demonstrate that the diabetic state produces an increase
in direct cholesteryl ester uptake by PerMWs, a finding that may
prove significant in continuing the search to delineate the
pathogenesis of diabetes-accelerated atherosclerosis.
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